Skip to main content

Advertisement

Open Peer Review Reports for: Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
12 Feb 2018 Submitted Original manuscript
15 Apr 2018 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 2
15 Apr 2018 Submitted Manuscript version 2
7 Jul 2018 Reviewed Reviewer Report - Pengfei Lei
18 Jul 2018 Reviewed Reviewer Report - Davide Maria Donati
10 Aug 2018 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 3
10 Aug 2018 Submitted Manuscript version 3
14 Nov 2018 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 4
14 Nov 2018 Submitted Manuscript version 4
28 Jan 2019 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 5
28 Jan 2019 Submitted Manuscript version 5
29 Jan 2019 Author responded Author comments - Akihiko Takeuchi
Resubmission - Version 6
29 Jan 2019 Submitted Manuscript version 6
Publishing
1 Feb 2019 Editorially accepted
9 Feb 2019 Article published 10.1186/s12891-019-2453-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement